The largest database of trusted experimental protocols

4 protocols using c 12221

1

Comparison of HUVEC and HCAEC Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs, pooled from up to four different donors per lot) and human coronary artery endothelial cells (HCAECs, single donor per lot) from different donors were purchased from Promocell (C-12203 and C-12221), and were utilized between passages 2 and 6. Experiments were repeated with endothelial cells from different lots. HUVECs and HCAECs were cultured in endothelial cell growth medium (Promocell; C-22010 and C-22020) or 2% (v/v) FBS endothelial cell basal medium (Promocell; C-22210 and C-22220) supplemented with 100 mg/mL penicillin and 100 IU/mL streptomycin. Human recombinant TNF-α protein was procured from R&D Systems (210-TA-20). Pharmacological inhibitor of β-catenin, iCRT-14, was acquired from Tocris Bioscience (4299). Cells were maintained in a humified atmosphere with 5% CO2 at 37°C.
+ Open protocol
+ Expand
2

Detecting Physiological Differences in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four experiments were needed to detect a physiologically relevant difference of 25% between control and intervention, given a standard deviation of 10%, a power of 80%, and an α of 0.05. Data are presented as mean ± standard deviation (SD). The distribution of the data was tested using the Shapiro-Wilk test. Normal distributed data were tested by one-way ANOVA with Bonferroni post hoc testing or by a Student’s t test. Non-normally distributed data were tested with Kruskal-Wallis and Mann-Whitney U test with Bonferroni correction. In each experiment, we attempted to avoid experimental bias by single-well use by pooling two wells with cells. The number of experiments mentioned in the figures refers to the number of technical replicates with cells from two donors (PCS-100-020 from ATCC, LOT# 59885589 and C-12221 from PromoCell, LOT# 425Z0191.1). Graphs were created in Graphpad Prism 8 and statistical analysis was performed using IBM SPSS Statistics 25. The cut-off values for statistical significance were indicated in the figures by *, **, and *** for p < 0.05, p < 0.01, and p < 0.001, respectively.
+ Open protocol
+ Expand
3

Cardioprotective Effects of Conditioned Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
L6 rat skeletal myoblasts (CRL-1458; ATCC, Manassas, USA), Huh7 human hepatoma cells (JCRB0403; JCRB Cell Bank, Osaka, Japan), MES13 mouse renal mesangial cells (CRL-1927; ATCC), primary human coronary artery endothelial cells (C-12221; PromoCell, Heidelberg, Germany), primary rat aortic smooth muscle cells, and primary rat hepatocytes were plated each on a 100 mm dish. These cells were incubated at 37 °C in DMEM containing 1% glucose (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS, antibiotics (Gibco, Waltham, USA), and non-essential amino acids (Gibco) to become confluent, and serum-starved for 24 hrs. Each conditioned medium was collected and filtered by a cell strainer (Thermo Fischer Scientific, Waltham, USA). In parallel, primary neonatal rat cardiomyocytes were serum-starved for 24 hrs and subjected to 10−6 M doxorubicin (Sigma-Aldrich, St. Louis, USA) for 12 hours or 1% hypoxia by AnaeroPack Kenki (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan) for 9 hrs, with or without administration of the above conditioned medium. After stimulation, Akt and caspase-3 activation was analyzed in cell lysates of the cardiomyocytes by Western blot.
+ Open protocol
+ Expand
4

Influence of RV on Endothelial Cell Viability and NO Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the influence of RV on endothelial cell viability and production of NO, human coronary artery endothelial cells (HCAEC, Promo cell, C-12221) were grown as a monolayer at 37°C under 5% CO2 atmosphere in EC growth medium MV (Promo cell, C-22020) supplemented with 5% foetal calf serum, 4 LmL -1 growth medium, 0.5 ng/mL -1 vascular endothelial growth factor, 10 ngmL -1 epidermal growth factor and 90 μgmL -1 heparin.
Before use, cells were washed three times in phosphate buffered saline (PBS) and then incubated with 0.1% trypsin for three minutes to detach them from the flask surface, centrifuged for 3 min at 220 g, and re-suspended in growth medium for seeding. Cells were seeded onto Nunc Thermanox coverslips (10,000 cells/coverslip; 13 mm diameter) (Thermo Fisher Scientific, USA) and allowed to proliferate for 24 hours (approximately 90% confluency). Half of the coverslips were kept in the well plate to perform the ACh assay while the other overslips were transferred into a millifluidic system made up of a bioreactor chamber (Kirkstall, UK) attached with a flow pump system in which increased flow was introduced [41] as indicated in the section below. All reagents were obtained from Sigma-Aldrich (Poole, UK), unless otherwise stated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!